HomeHUMA • NASDAQ
add
Humacyte Inc
Previous close
$6.42
Day range
$6.18 - $6.96
Year range
$1.96 - $6.96
Market cap
770.48M USD
Avg Volume
1.73M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 5.31M | 1.53% |
Net income | -31.90M | 13.72% |
Net profit margin | — | — |
Earnings per share | -0.25 | -14.32% |
EBITDA | -24.65M | -20.59% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 115.50M | -12.28% |
Total assets | 161.47M | -11.76% |
Total liabilities | 135.31M | 33.86% |
Total equity | 26.15M | — |
Shares outstanding | 108.25M | — |
Price to book | 26.75 | — |
Return on assets | -45.87% | — |
Return on capital | -160.77% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -31.90M | 13.72% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
Jan 1, 2004
Website
Employees
184